Datril is a new analgesic made by Bristol-Myer’s that is classified as containing acetaminophen. This case deals with Datril’s market penetration and positioning as compared to their competitor, Tylenol. I believe that Datril should be positioned as the newest addition to the Bristol-Myer’s family and priced at the same point as Tylenol. This approach will allow all the advertising to focus on the drug’s unique selling points as an acetaminophen as compared to an aspirin, while having the back bone of the Bristol-Myer’s name. This tactic will draw in those customers who already trust and use the Bristol-Myer’s brand.
Clorox also has a large marketing budget, an experienced research and development team and most importantly, brand recognition. Clorox can use their large market share to attract customers to new or improved products. Also brand recognition will be very important in the sale of the faucet filtration systems. They claim to have the best tasting water and according to their research, customers are more concerned about taste than removing contaminants. Even though the Brita products are a bit more expensive, people are willing to pay at that price for greater tasted water.
Apex should consider beta entry as an application innovation and a line extension to its current stigone market. Line extensions can provide low risk, given established reputation and customer base, and high revenues. Leveraging these two aspects, along with current category momentum, can generate high returns, Moore (pg 108-109). Apex can capitalize on their established brand and current stigone products and now redirect their efforts in the same market instead of starting over, Moore (pg 80). By continuing in the
In addition, the team wanted to launch and develop a new antidepressant. This being the reason, Kaiser the marketing direct at Eli Lilly and company decided to come up with an alternative, and the New Antidepressant Team (NAT) decided on Cymbalta. The main reason behind this pick was because Cymbalta appeared to be better than Prozac, no safety or toxicity issues, and more customer demand. Keiser was analyzing his ideas about investing on large skills clinical trials or invest on a clinical trials for a new suggestion. However, Kaiser didn’t know that the new director of commercial development for Cymbalta Jim Lancaster was also headed toward the meeting with different mindset.
Wound healing outcomes, described as epithelisation, reduction in size and healing rate, were significantly improved in the experimental group. Thus, Manuka honey was shown to be a superior treatment for chronic venous leg ulcers in one of the experimental measures (Gethin & Cowman, 2008). Limitations of this study included inability to blind examiners to treatment type (since Manuka honey stained the skin orange), and the limited number of participants. The researchers did attempt to minimize possible bias in examiners through other measures such as using several different examiners from different centers, quantitatively measuring wound tissue type and a standardized method of wound measurement. Increasing the number of participants was described as being “unrealistic” for this experiment (Gethin & Cowman,
Proponents claim it benefits consumers with knowledge of various illnesses and the possible treatments available to them. While opponents argue the negative connotations of drug abuse, increased drug costs and long term health concerns. As with any issue like this, ethics come into question; Is this ethically
(b) How would you implement your recommendation? Enter the market as soon as possible, thus leveraging the early mover advantages such as brand loyalty and market share. Obtain the patent for the technology so that the competitors cannot copy the technology and if they did copy they cannot sell it till the patent has expired. Establish partnerships with U.S subsidiaries who know how the market operates and have some experience in reaching out to the market. Conduct studies with medical professionals in the U.S such as surgeons so that the awareness of the CT scanner’s superior technology reaches out faster and thus recommended by medical professionals.
The money needed for HPV/cervical cancer treatment greatly surpasses that of the price of the Gardasil shots. By making them mandatory, it allows people to get ahead of the virus before it takes a hold of their immune systems. Merino is wrong when he says that there is no rush to receiving the vaccine. Waiting too long may be the difference between a three hundred dollar medical bill and a seventy thousand dollar medical bill. Staying ahead of the curve, by mandating the Gardasil shot is a great way to stay safe, and be protected seventy percent more than if not given the
With this formula, SFPG aims to target customers by stating the superiority of the product due to its high degree of protection from odour and wetness. The concept statement also states that it is a unisex product with an aim to target wider customer base, not just limiting it to one sex. This way they reduce on production costs as well. The new product will be available in two sizes costing $3.50 and $2.20 per unit basis. Good to mention the pricing as it is easier to categorize it in a particular section in retail outlet.
It is amazing what these technologies have provided but the question that comes up is will that medical technology being used change the outcome of a patients illness and overall treatment? It is inevitable that technology will continue to change the medical fields but it has to be used appropriately and not overused if we are to lower costs. I believe that demands will continue to increase; my solution to this is to have physicians develop protocols and standards that are proven in the use of new technologies to see if the patient will truly get a benefit out of it. If the protocol does not prove that a patient will benefit from the use of the technology, then the procedure should not be